Home > Cashflow Statement > INDOCO REMEDIES

INDOCO REMEDIES
Cashflow Statement

INDOCO REMEDIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for INDOCO REMEDIES
Please provide your vote to see the results

INDOCO REMEDIES Last 5 Year Cashflow Statement History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Profit Before Tax₹124 Cr₹193 Cr₹237 Cr₹132 Cr₹29 Cr
Adjustment ₹138 Cr₹121 Cr₹87 Cr₹110 Cr₹100 Cr
Changes In working Capital ₹-87 Cr₹-73 Cr₹-109 Cr₹-140 Cr₹-1.49 Cr
Cash Flow after changes in Working Capital ₹175 Cr₹240 Cr₹215 Cr₹102 Cr₹127 Cr
Cash Flow from Operating Activities ₹157 Cr₹179 Cr₹174 Cr₹82 Cr₹123 Cr
Cash Flow from Investing Activities ₹-434 Cr₹-208 Cr₹-121 Cr₹-67 Cr₹-56 Cr
Cash Flow from Financing Activities ₹280 Cr₹23 Cr₹-44 Cr₹-30 Cr₹-64 Cr
Net Cash Inflow / Outflow ₹3.31 Cr₹-6.53 Cr₹8.05 Cr₹-14 Cr₹2.97 Cr
Opening Cash & Cash Equivalents ₹12 Cr₹17 Cr₹9.42 Cr₹24 Cr₹21 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations -----
Closing Cash & Cash Equivalent ₹15 Cr₹11 Cr₹17 Cr₹9.42 Cr₹24 Cr

Compare Cashflow Statement of peers of INDOCO REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDOCO REMEDIES ₹2,222.9 Cr 1.5% -2.7% -28.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,648.0 Cr -4.9% 2.1% 15.5% Stock Analytics
DIVIS LABORATORIES ₹159,310.0 Cr -2.2% 9.3% 50.5% Stock Analytics
CIPLA ₹119,410.0 Cr -4.2% 4.5% 4.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹106,189.0 Cr -4.4% -4.5% 17.2% Stock Analytics
DR REDDYS LABORATORIES ₹96,496.4 Cr -1.4% 4.2% -8.8% Stock Analytics


INDOCO REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
INDOCO REMEDIES

1.5%

-2.7%

-28.1%

SENSEX

-1.3%

4.1%

7.6%


You may also like the below Video Courses